These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33535007)

  • 41. Guillain-Barre Syndrome Associated With COVID-19 Pneumonia-The First Documented Case in a U.S. Military Intensive Care Unit.
    Yiu AC; Hussain A; Okonkwo UA; Villacorta-Lyew R; McMahon MJ; Blattner M
    Mil Med; 2023 Mar; 188(3-4):e852-e856. PubMed ID: 33881526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.
    Shoraka S; Ferreira MLB; Mohebbi SR; Ghaemi A
    Front Immunol; 2021; 12():674922. PubMed ID: 34040615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Guillain Barre Syndrome following delivery in a pregnant woman infected with SARS-CoV-2.
    Tekin AB; Zanapalioglu U; Gulmez S; Akarsu I; Yassa M; Tug N
    J Clin Neurosci; 2021 Apr; 86():190-192. PubMed ID: 33775326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital.
    Ottaviani D; Boso F; Tranquillini E; Gapeni I; Pedrotti G; Cozzio S; Guarrera GM; Giometto B
    Neurol Sci; 2020 Jun; 41(6):1351-1354. PubMed ID: 32399950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A unique case of Miller Fisher-Guillain-Barré overlap syndrome in a liver transplant recipient.
    Ramirez-Sanchez C; Syed R; Meier A; LaBuzetta JN; Hylton DJ; Taremi M
    J Neurovirol; 2021 Oct; 27(5):797-801. PubMed ID: 34550544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Urodynamic AUR in Guillain-Barré syndrome post-infection by coronavirus Sars-CoV-2. A bibliographic review.].
    Méndez-Rubio S; Laso-Martín S; Jerez-Izquierdo T; Lorenzo-García C; López-Pérez E; Vives-Dilme R; Fernández-Hernández L; Méndez-Cea B; Moreno-Sierra J; Virseda-Chamorro M; Salinas-Casado J
    Arch Esp Urol; 2022 Jan; 75(1):7-18. PubMed ID: 35173070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Late onset of Guillain-Barré syndrome following SARS-CoV-2 infection: part of 'long COVID-19 syndrome'?
    Raahimi MM; Kane A; Moore CE; Alareed AW
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication.
    Chakraborty U; Hati A; Chandra A
    Diabetes Metab Syndr; 2021; 15(6):102326. PubMed ID: 34731822
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concurrence of Guillain-Barré syndrome and primary biliary cholangitis not related to SARS-CoV-2: Case report.
    Segura-Chávez D; Tagle-Lostaunau I; Sifuentes-Monge J; Aquino-Peña F
    Medwave; 2023 Apr; 23(3):. PubMed ID: 37115660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Guillain-Barre syndrome associated with COVID-19].
    Bogdanova AA; Kravtsunova ES; Raevskaia AI; Karpov AS; Gadaborshev RN; Dzutsev AI; Vyshlova IA; Karpov SM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(9):132-136. PubMed ID: 36168699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Guillain-Barré-Strohl syndrome and COVID-19: Case report and literature review.
    Diez-Porras L; Vergés E; Gil F; Vidal MJ; Massons J; Arboix A
    Neuromuscul Disord; 2020 Oct; 30(10):859-861. PubMed ID: 32912716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Guillain-Barre syndrome with cranial nerve damage as complication of COVID-19].
    Shakaryan AK; Pylaeva SK; Perekopskaya NE; Sayfullin RF; Belyakova AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(9):100-103. PubMed ID: 34693696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review.
    Aladawi M; Elfil M; Abu-Esheh B; Abu Jazar D; Armouti A; Bayoumi A; Piccione E
    Can J Neurol Sci; 2022 Jan; 49(1):38-48. PubMed ID: 33949300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Guillain-Barré syndrome in patients with SARS-CoV-2 infection. Report of three cases.
    Cea G; Romero C; Aguilar S; Salinas R
    Rev Med Chil; 2021 Dec; 149(12):1812-1816. PubMed ID: 35735350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?
    Khan F; Sharma P; Pandey S; Sharma D; V V; Kumar N; Shukla S; Dandu H; Jain A; Garg RK; Malhotra HS
    J Med Virol; 2021 Oct; 93(10):6045-6049. PubMed ID: 34170552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection in a Pediatric Patient.
    Frank CHM; Almeida TVR; Marques EA; de Sousa Monteiro Q; Feitoza PVS; Borba MGS; Vasconcelos HL; de Souza Bastos M; Lacerda MVG
    J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 32653906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SARS-CoV-2 and Guillain-Barré Syndrome: Lessons from Viral Infections.
    Meidaninikjeh S; Sabouni N; Taheri M; Borjkhani M; Bengar S; Majidi Zolbanin N; Khalili A; Jafari R
    Viral Immunol; 2022 Jul; 35(6):404-417. PubMed ID: 35766944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Guillain-Barré syndrome as only manifestation of COVID-19 infection.
    d'Orsi G; Sica S; Maiorano A; Melchionda D; Lalla A; Montemurro L; Sabetta A; Goffredo R; Lecce B; Fiore JR; Santantonio T; Avolio C
    Clin Neurol Neurosurg; 2021 Aug; 207():106775. PubMed ID: 34175645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guillain-Barré syndrome associated with COVID-19 disease.
    Korem S; Gandhi H; Dayag DB
    BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32958554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome.
    Hilts A; Schreiber A; Singh A
    Am J Case Rep; 2022 Aug; 23():e936896. PubMed ID: 35945825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.